Phosphoproteomics of primary human FLT3-ITD+ AML cells treated with gilteritinib
收藏NIAID Data Ecosystem2026-03-13 收录
下载链接：
https://www.omicsdi.org/dataset/pride/PXD034080
下载链接
链接失效反馈官方服务：
资源简介：
Primary human AML cells (newly diagnosed, prior to treatment initation) were obtained from donor after consent and AML blasts were isolated by standard Ficoll centrifugation. AML blasts were treated with FLT3 inhibitor gilteritinib (or DMSO vehicle control) at 10 nM concentration for 6 h, followed by harvest for LC/MS.
创建时间：
2022-08-25
